H. Yosef

630 total citations
13 papers, 380 citations indexed

About

H. Yosef is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Yosef has authored 13 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Yosef's work include Head and Neck Cancer Studies (3 papers), Colorectal and Anal Carcinomas (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). H. Yosef is often cited by papers focused on Head and Neck Cancer Studies (3 papers), Colorectal and Anal Carcinomas (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). H. Yosef collaborates with scholars based in United Kingdom and Australia. H. Yosef's co-authors include N.S. Reed, J.T. Roberts, E. Grosch, M.H. Cullen, A.D. Chetiyawardana, William G. Jones, Gillian Duchesne, John R. Owen, A. Horwich and Sophie D. Fosså and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

H. Yosef

13 papers receiving 367 citations

Peers

H. Yosef

SURGE

RHEUM

PRM

NEURO

B Court France

Kou Kaneko Japan

Steven A. Clark United States

Toshiji Nishi Japan

G. Jay United Kingdom

R Curík Czechia

Peter Mencel United States

Calogero Virgone Italy

Samuel J. Insalaco United States

Sigurd Ous Norway

B Court France

H. Yosef

305 ×1.0

SURGE

152 ×1.0

RHEUM

179 ×2.0

PRM

46 ×0.5

NEURO

96 ×1.2

Citations per year, relative to H. Yosef H. Yosef (= 1×) peers B Court

Countries citing papers authored by H. Yosef

Since Specialization

Citations

This map shows the geographic impact of H. Yosef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Yosef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Yosef more than expected).

Fields of papers citing papers by H. Yosef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Yosef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Yosef. The network helps show where H. Yosef may publish in the future.

Co-authorship network of co-authors of H. Yosef

This figure shows the co-authorship network connecting the top 25 collaborators of H. Yosef. A scholar is included among the top collaborators of H. Yosef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Yosef. H. Yosef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Palmieri, Carlo, Vivek Misra, Adam Januszewski, et al.. (2013). Multicenter Experience of Nonpegylated Liposomal Doxorubicin Use in the Management of Metastatic Breast Cancer. Clinical Breast Cancer. 14(2). 85–93. 11 indexed citations

Armour, Alison, et al.. (2003). 34 Prognostic factors in patients with small cell lung cancer. Lung Cancer. 41. S282–S282. 1 indexed citations

Symonds, R.P., T. Habeshaw, Nicholas S. Reed, et al.. (2000). The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer. European Journal of Cancer. 36(8). 994–1001. 21 indexed citations

Fosså, Sophie D., A. Horwich, J.T. Roberts, et al.. (1999). Optimal Planning Target Volume for Stage I Testicular Seminoma: A Medical Research Council Randomized Trial. Journal of Clinical Oncology. 17(4). 1146–1146. 255 indexed citations

Cassidy, Jim, et al.. (1998). Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalation. British Journal of Cancer. 77(9). 1480–1486. 3 indexed citations

Kerr, David, Jim Cassidy, M. Soukop, et al.. (1996). A pilot study of combination therapy with interferon-α-2a and 5-fluorouracil in metastatic carcinoid and malignant endocrine pancreatic tumours. Annals of Oncology. 7(2). 208–210. 25 indexed citations

Cowie, V.J., T. Habeshaw, Elizabeth Junor, et al.. (1996). A short and intensive single-agent cisplatin regimen for recurrent carcinoma of the uterine cervix. International Journal of Gynecological Cancer. 6(1). 61–67. 7 indexed citations

Adams, Malcolm, M. Soukop, V. Barley, et al.. (1995). Tropisetron alone or in combination with dexamethasone for the prevention and treatment of emesis induced by non-cisplatin chemotherapy. Anti-Cancer Drugs. 6(4). 514–521. 13 indexed citations

Jodrell, Duncan I., Wolfgang Oster, David J. Kerr, et al.. (1994). A phase I–II study of N-(phosphonacetyl)-l-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancer. European Journal of Cancer. 30(7). 950–954. 2 indexed citations

10.

Junor, Elizabeth, Peter Canney, & H. Yosef. (1993). Carboplatin and 5-fluorouracil in advanced and recurrent squamous carcinoma of the head and neck. Clinical Oncology. 5(1). 43–45. 4 indexed citations

11.

Yosef, H., C.W. Keen, H. F. Hope-Stone, et al.. (1993). Prednimustine (sterecyt) versus cyclophosphamide both in combination with methotrexate and 5-fluorouracil in the treatment of advanced breast cancer. European Journal of Cancer. 29(8). 1100–1105. 8 indexed citations

12.

Cole, Daniel J., et al.. (1992). A pilot study of accelerated fractionation in the radiotherapy of invasive carcinoma of the bladder. British Journal of Radiology. 65(777). 792–798. 28 indexed citations

13.

Robertson, Andrew, et al.. (1982). Cancer of larynx in west of Scotland. American Journal of Clinical Oncology. 5(5). 527–533. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact